BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 37033225)

  • 1. The characteristics of serum lipid spectrum in PanNENs and its correlation with clinicopathological features and prognosis.
    Meng YF; Fan ZY; Yang J; Li YZ; Liu SJ; Gao CH; Gao X; Pang CY; Zhan HX
    Front Endocrinol (Lausanne); 2023; 14():1137911. PubMed ID: 37033225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes of serum lipid profiles and the correlation analysis in clinic-pathological features of pancreatic cancer patients].
    Yang J; Fan ZY; Li YZ; Liu SJ; Meng YF; Xu JW; Wang L; Zhan HX
    Zhonghua Wai Ke Za Zhi; 2022 Jul; 60(7):680-687. PubMed ID: 35775261
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative outcomes of pancreatic neuroendocrine neoplasms: A population-based analysis of the SEER database.
    Yang Z; Shi G
    Eur J Surg Oncol; 2022 Oct; 48(10):2181-2187. PubMed ID: 35623986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural history and clinical outcomes of pancreatic neuroendocrine neoplasms based on the WHO 2017 classification; a single-center experience of 30 years.
    Fujimori N; Miki M; Lee L; Matsumoto K; Takamatsu Y; Takaoka T; Teramatsu K; Suehiro Y; Murakami M; Igarashi H; Oono T; Ohtsuka T; Nakamura M; Koga Y; Oda Y; Ito T; Ogawa Y
    Pancreatology; 2020 Jun; 20(4):709-715. PubMed ID: 32360001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of tumour burden in stage IV neuroendocrine neoplasia: A comparison between pancreatic and gastrointestinal localizations.
    Panzuto F; Pusceddu S; Faggiano A; Rinzivillo M; Brighi N; Prinzi N; Riccardi F; Iannicelli E; Maggio I; Femia D; Tafuto S; Manuzzi L; Di Sarno A; Annibale B; de Braud F; Campana D;
    Pancreatology; 2019 Dec; 19(8):1067-1073. PubMed ID: 31587962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcitonin-Producing Neuroendocrine Neoplasms of the Pancreas: Clinicopathological Study of 25 Cases and Review of the Literature.
    Uccella S; Blank A; Maragliano R; Sessa F; Perren A; La Rosa S
    Endocr Pathol; 2017 Dec; 28(4):351-361. PubMed ID: 29063495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progesteron receptor expression in insulin producing cells of neuroendocrine neoplasms.
    Tachibana T; Kasajima A; Aoki T; Tabata T; McNamara K; Yazdani S; Satoko S; Fujishima F; Motoi F; Unno M; Sasano H
    J Steroid Biochem Mol Biol; 2020 Jul; 201():105694. PubMed ID: 32437964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin immunoreactive pancreatic neuroendocrine neoplasm associated with main pancreatic duct dilation: a recognizable entity with excellent long-term outcome.
    Dioguardi Burgio M; Cros J; Panvini N; Depoilly T; Couvelard A; Ruszniewski P; de Mestier L; Hentic O; Sauvanet A; Dokmak S; Faccinetto A; Ronot M; Vilgrain V
    Eur Radiol; 2021 Nov; 31(11):8671-8681. PubMed ID: 33977308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic relevance of proliferation-related miRNAs in pancreatic neuroendocrine neoplasms.
    Grolmusz VK; Kövesdi A; Borks K; Igaz P; Patócs A
    Eur J Endocrinol; 2018 Oct; 179(4):219-228. PubMed ID: 30299890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Characteristics and Management of Functional Pancreatic Neuroendocrine Neoplasms: A Single Institution 20-Year Experience with 286 Patients.
    Qu Y; Li H; Wang X; Chen Y; Guo Q; Pei Y; Du J; Dou J; Ba J; Lv Z; Mu Y
    Int J Endocrinol; 2020; 2020():1030518. PubMed ID: 33204258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Clinicopathologic and Molecular Update of Pancreatic Neuroendocrine Neoplasms With a Focus on the New World Health Organization Classification.
    Fang JM; Shi J
    Arch Pathol Lab Med; 2019 Nov; 143(11):1317-1326. PubMed ID: 31509453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The number of positive nodes accurately predicts recurrence after pancreaticoduodenectomy for nonfunctioning neuroendocrine neoplasms.
    Partelli S; Javed AA; Andreasi V; He J; Muffatti F; Weiss MJ; Sessa F; La Rosa S; Doglioni C; Zamboni G; Wolfgang CL; Falconi M
    Eur J Surg Oncol; 2018 Jun; 44(6):778-783. PubMed ID: 29610023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct clinicopathological and prognostic features of insulinoma with synchronous distant metastasis.
    Gao H; Wang W; Xu H; Wu C; Jin W; Zhang S; Xu J; Ni Q; Yu X; Liu L
    Pancreatology; 2019 Apr; 19(3):472-477. PubMed ID: 30850220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences and Similarities in the Clinicopathological Features of Pancreatic Neuroendocrine Tumors in China and the United States: A Multicenter Study.
    Zhu LM; Tang L; Qiao XW; Wolin E; Nissen NN; Dhall D; Chen J; Shen L; Chi Y; Yuan YZ; Ben QW; Lv B; Zhou YR; Bai CM; Chen J; Song YL; Song TT; Lu CM; Yu R; Chen YJ
    Medicine (Baltimore); 2016 Feb; 95(7):e2836. PubMed ID: 26886644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival comparison between primary hepatic neuroendocrine neoplasms and primary pancreatic neuroendocrine neoplasms and the analysis on prognosis-related factors.
    Li MX; Li QY; Xiao M; Wan DL; Chen XH; Zhou L; Xie HY; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2019 Dec; 18(6):538-545. PubMed ID: 30981633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of multiomics sequencing and advances in the molecular mechanisms of pancreatic neuroendocrine neoplasms.
    Jiang R; Hong X; Zhao Y; Wu W
    Cancer Lett; 2021 Feb; 499():39-48. PubMed ID: 33246093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of intratumoral perfusion analysis for assessing biological features of non-functional pancreatic neuroendocrine neoplasm.
    Notake T; Shimizu A; Kubota K; Sugenoya S; Umemura K; Goto T; Yamada A; Fujinaga Y; Soejima Y
    Langenbecks Arch Surg; 2024 Jan; 409(1):38. PubMed ID: 38221590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The associations between serum high-density lipoprotein cholesterol levels and malignant behavior in pancreatic neuroendocrine neoplasms.
    Quan L; Liu Y; Cui W; Wang X; Zhang W; Wang Z; Guo C; Lu C; Hu F; Chen X
    Lipids Health Dis; 2022 Jul; 21(1):58. PubMed ID: 35842659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High minichromosome maintenance protein 7 proliferation indices: a powerful predictor of progression in pancreatic neuroendocrine neoplasms without distant metastasis at the time of surgery.
    Ban X; Yan J; Yu S; Lu Z; Chang X; Jia C; Gao C; Shao H; Wu Y; Mao X; Zhang Y; Li Y; Chen J
    Hum Pathol; 2019 Mar; 85():101-111. PubMed ID: 30447299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the Role of Operative Intervention in Elderly Patients With Nonfunctional Pancreatic Neuroendocrine Neoplasms.
    Hue JJ; Sugumar K; Mohamed A; Selfridge JE; Bajor D; Hardacre JM; Ammori JB; Rothermel LD; Winter JM; Ocuin LM
    Pancreas; 2022 Apr; 51(4):380-387. PubMed ID: 35695765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.